Trillium Therapeutics Inc. (TRIL) NASDAQ
$18.44 - (-)
Market Cap: -
As of 11/16/21 12:00 AM EST. Market closed.

Trillium Therapeutics Inc. (TRIL)
NASDAQ
$18.44
- (-)
Market Cap: -
As of 11/16/21 12:00 AM EST. Market closed.
Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune ... read more
Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune system. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Uger Robert | Chief Scientific Officer | Jul 07, 2021 | Option Exercise | $0.30 | 3,646 | 1,108 | 3,646 | Jul 09, 2021, 04:30 PM |
Uger Robert | Chief Scientific Officer | Jul 07, 2021 | Sale | $9.00 | 3,646 | 32,814 | 0 | Jul 09, 2021, 04:30 PM |
Uger Robert | Chief Scientific Officer | Apr 07, 2021 | Option Exercise | $0.30 | 3,646 | 1,098 | 3,646 | Apr 09, 2021, 05:38 PM |
Uger Robert | Chief Scientific Officer | Apr 07, 2021 | Sale | $10.82 | 3,646 | 39,450 | 0 | Apr 09, 2021, 05:38 PM |
Petrova Penka | Chief Development Officer | Apr 08, 2021 | Option Exercise | $1.80 | 5,312 | 9,578 | 5,312 | Apr 09, 2021, 05:23 PM |
Petrova Penka | Chief Development Officer | Apr 08, 2021 | Sale | $11.09 | 5,312 | 58,910 | 0 | Apr 09, 2021, 05:23 PM |
Uger Robert | Chief Scientific Officer | Mar 12, 2021 | Option Exercise | $3.39 | 2,917 | 9,896 | 2,917 | Mar 15, 2021, 05:12 PM |
Uger Robert | Chief Scientific Officer | Mar 12, 2021 | Sale | $11.97 | 2,917 | 34,916 | 0 | Mar 15, 2021, 05:12 PM |
Petrova Penka | Chief Development Officer | Mar 10, 2021 | Option Exercise | $1.80 | 5,312 | 9,545 | 5,312 | Mar 12, 2021, 04:40 PM |
Petrova Penka | Chief Development Officer | Mar 10, 2021 | Sale | $11.08 | 5,312 | 58,857 | 0 | Mar 12, 2021, 04:40 PM |
Uger Robert | Chief Scientific Officer | Mar 08, 2021 | Option Exercise | $0.30 | 3,646 | 1,093 | 3,646 | Mar 10, 2021, 05:57 PM |
Uger Robert | Chief Scientific Officer | Mar 08, 2021 | Sale | $10.11 | 3,646 | 36,861 | 0 | Mar 10, 2021, 05:57 PM |
Petrova Penka | Chief Development Officer | Feb 09, 2021 | Option Exercise | $9.62 | 508 | 4,888 | 508 | Feb 10, 2021, 07:18 PM |
Petrova Penka | Chief Development Officer | Feb 08, 2021 | Option Exercise | $1.78 | 5,312 | 9,435 | 5,312 | Feb 10, 2021, 07:18 PM |
Petrova Penka | Chief Development Officer | Feb 09, 2021 | Sale | $14.17 | 508 | 7,200 | 0 | Feb 10, 2021, 07:18 PM |
Petrova Penka | Chief Development Officer | Feb 08, 2021 | Sale | $12.65 | 5,312 | 67,197 | 0 | Feb 10, 2021, 07:18 PM |
Uger Robert | Chief Scientific Officer | Feb 09, 2021 | Option Exercise | $9.62 | 584 | 5,619 | 584 | Feb 10, 2021, 07:18 PM |
Uger Robert | Chief Scientific Officer | Feb 08, 2021 | Option Exercise | $1.64 | 6,563 | 10,751 | 6,563 | Feb 10, 2021, 07:18 PM |
Uger Robert | Chief Scientific Officer | Feb 09, 2021 | Sale | $14.12 | 584 | 8,248 | 0 | Feb 10, 2021, 07:18 PM |
Uger Robert | Chief Scientific Officer | Feb 08, 2021 | Sale | $12.65 | 6,563 | 83,022 | 0 | Feb 10, 2021, 07:18 PM |
Skvarka Jan | President and CEO | Jan 13, 2021 | Option Exercise | $0.42 | 5,419 | 2,302 | 5,419 | Jan 15, 2021, 04:19 PM |
Skvarka Jan | President and CEO | Jan 14, 2021 | Option Exercise | $0.43 | 19,581 | 8,371 | 19,581 | Jan 15, 2021, 04:19 PM |
Skvarka Jan | President and CEO | Jan 13, 2021 | Sale | $15.04 | 5,419 | 81,508 | 0 | Jan 15, 2021, 04:19 PM |
Skvarka Jan | President and CEO | Jan 14, 2021 | Sale | $15.03 | 19,581 | 294,279 | 0 | Jan 15, 2021, 04:19 PM |
Uger Robert | Chief Scientific Officer | Jan 11, 2021 | Option Exercise | $9.57 | 584 | 5,587 | 584 | Jan 13, 2021, 04:12 PM |
Uger Robert | Chief Scientific Officer | Jan 11, 2021 | Sale | $15.20 | 584 | 8,879 | 0 | Jan 13, 2021, 04:12 PM |
Petrova Penka | Chief Development Officer | Jan 11, 2021 | Option Exercise | $9.57 | 508 | 4,860 | 508 | Jan 13, 2021, 04:11 PM |
Petrova Penka | Chief Development Officer | Jan 11, 2021 | Sale | $15.21 | 508 | 7,725 | 0 | Jan 13, 2021, 04:11 PM |
Parsons James T. | Chief Financial Officer | Jan 08, 2021 | Option Exercise | $7.24 | 8,505 | 61,616 | 8,505 | Jan 12, 2021, 04:12 PM |
Parsons James T. | Chief Financial Officer | Jan 08, 2021 | Sale | $15.79 | 8,505 | 134,271 | 0 | Jan 12, 2021, 04:12 PM |
Uger Robert | Chief Scientific Officer | Jan 08, 2021 | Option Exercise | $8.38 | 8,517 | 71,365 | 5,600 | Jan 12, 2021, 04:11 PM |
Uger Robert | Chief Scientific Officer | Jan 08, 2021 | Sale | $15.71 | 8,517 | 133,806 | 0 | Jan 12, 2021, 04:11 PM |
Petrova Penka | Chief Development Officer | Jan 08, 2021 | Option Exercise | $3.33 | 2,604 | 8,674 | 2,604 | Jan 12, 2021, 04:10 PM |
Petrova Penka | Chief Development Officer | Jan 08, 2021 | Sale | $15.50 | 2,604 | 40,365 | 0 | Jan 12, 2021, 04:10 PM |
Petrova Penka | Chief Development Officer | Jan 07, 2021 | Option Exercise | $0.30 | 2,708 | 809 | 2,708 | Jan 11, 2021, 04:19 PM |
Petrova Penka | Chief Development Officer | Jan 07, 2021 | Sale | $14.71 | 2,708 | 39,843 | 0 | Jan 11, 2021, 04:19 PM |
Uger Robert | Chief Scientific Officer | Jan 07, 2021 | Option Exercise | $0.30 | 3,646 | 1,089 | 3,646 | Jan 11, 2021, 04:17 PM |
Uger Robert | Chief Scientific Officer | Jan 07, 2021 | Sale | $14.75 | 3,646 | 53,782 | 0 | Jan 11, 2021, 04:17 PM |
Owner | Relationship | Date | Value($) |
Uger Robert | Chief Scientific Officer | 07/07/2021 | 1,108 |
Uger Robert | Chief Scientific Officer | 07/07/2021 | 32,814 |
Uger Robert | Chief Scientific Officer | 04/07/2021 | 1,098 |
Uger Robert | Chief Scientific Officer | 04/07/2021 | 39,450 |
Petrova Penka | Chief Development Officer | 04/08/2021 | 9,578 |
Petrova Penka | Chief Development Officer | 04/08/2021 | 58,910 |
Uger Robert | Chief Scientific Officer | 03/12/2021 | 9,896 |
Uger Robert | Chief Scientific Officer | 03/12/2021 | 34,916 |
Petrova Penka | Chief Development Officer | 03/10/2021 | 9,545 |
Petrova Penka | Chief Development Officer | 03/10/2021 | 58,857 |
Uger Robert | Chief Scientific Officer | 03/08/2021 | 1,093 |
Uger Robert | Chief Scientific Officer | 03/08/2021 | 36,861 |
Petrova Penka | Chief Development Officer | 02/09/2021 | 4,888 |
Petrova Penka | Chief Development Officer | 02/08/2021 | 9,435 |
Petrova Penka | Chief Development Officer | 02/09/2021 | 7,200 |
Petrova Penka | Chief Development Officer | 02/08/2021 | 67,197 |
Uger Robert | Chief Scientific Officer | 02/09/2021 | 5,619 |
Uger Robert | Chief Scientific Officer | 02/08/2021 | 10,751 |
Uger Robert | Chief Scientific Officer | 02/09/2021 | 8,248 |
Uger Robert | Chief Scientific Officer | 02/08/2021 | 83,022 |
Skvarka Jan | President and CEO | 01/13/2021 | 2,302 |
Skvarka Jan | President and CEO | 01/14/2021 | 8,371 |
Skvarka Jan | President and CEO | 01/13/2021 | 81,508 |
Skvarka Jan | President and CEO | 01/14/2021 | 294,279 |
Uger Robert | Chief Scientific Officer | 01/11/2021 | 5,587 |
Uger Robert | Chief Scientific Officer | 01/11/2021 | 8,879 |
Petrova Penka | Chief Development Officer | 01/11/2021 | 4,860 |
Petrova Penka | Chief Development Officer | 01/11/2021 | 7,725 |
Parsons James T. | Chief Financial Officer | 01/08/2021 | 61,616 |
Parsons James T. | Chief Financial Officer | 01/08/2021 | 134,271 |
Uger Robert | Chief Scientific Officer | 01/08/2021 | 71,365 |
Uger Robert | Chief Scientific Officer | 01/08/2021 | 133,806 |
Petrova Penka | Chief Development Officer | 01/08/2021 | 8,674 |
Petrova Penka | Chief Development Officer | 01/08/2021 | 40,365 |
Petrova Penka | Chief Development Officer | 01/07/2021 | 809 |
Petrova Penka | Chief Development Officer | 01/07/2021 | 39,843 |
Uger Robert | Chief Scientific Officer | 01/07/2021 | 1,089 |
Uger Robert | Chief Scientific Officer | 01/07/2021 | 53,782 |